Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)

Sponsor
IRCCS San Raffaele
Study ID
NCT06306170
Status
Recruiting
Apply to this trial

Conditions

  • Gynecologic Cancer
  • Progression, Clinical
  • Progression, Disease
  • Radiotherapy Side Effect
  • Radiotherapy; Complications
  • Survivorship

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • Image Guided Radiotherapy — RADIATION
    Patients treated with IGRT, IMRT, SBRT for Gynecological cancer will be evaluated

Study Details

This is an observational mono-institutional study. Patients with gynecologic tumors treated with advanced radiotherapy- Image Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Body Radiotherapy (SBRT)- will be included and toxicity and outcomes analyzed.

Key Dates

First listed
Mar 12, 2024
Start date
Feb 15, 2024
Status verified
Apr 2025
Primary completion
Feb 15, 2027
Completion
Feb 15, 2029

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Gynecologic cancer patients
    Gynecologic cancer patients treated with IGRT, IMRT, SBRT (advanced radiotherapy-ART)

Primary Outcome Measure

Local Relapse Free Survival [ Time Frame: From date of radiotherapy end until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 120 months ]

Central Contacts

Related Studies